Clinical Trial Update: Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

View source ↗

Summary

This clinical trial update describes a study investigating genomic, proteomic, and dosimetric determinants of late toxicity after three-dimensional conformal ra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Prostate Cancer | Status: TERMINATED